This HND piece focuses on serious vagaries in how a particular controlled substance, CBD, is regulated. The case discussed involves Epidiolex, a CBD isolate recently FDA-approved for certain seizure disorders.
CBD is considered a Schedule I substance, which means that it has no approved medical usage. But, I guess it now does, so what is to be done? Let's just say that what the Feds did pleased the makers of Epidiolex...and no one else. Regulatory politics at its absolute worst.
Read the complete article.